Esposito Pamela — SEC Form 4 filings
SEC reporting owner CIK 1744425. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-25.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-20 to 2026-06-25. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 16 legs across 7 filings — 59,063 shares, $4,073,600 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 27.
- Largest priced transaction: sale of 14,505 shares @ $81.56 ($1,182,984) in Kymera Therapeutics, Inc., filed 2025-12-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | Director | 11 | — | 16 legs · 59,063 sh · $4,073,600 | 27 |
Form 4 filings — Esposito Pamela
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-25 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 6,068 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 1,000 @ $31.20 · Option exercise (M): 1,000 (derivative) @ $0 | EDGAR |
| 2026-03-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,500 @ $49.10 · Sale (S): 700 @ $77.71 · Sale (S): 600 @ $79.24 · Sale (S): 1,200 @ $79.94 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-02-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,500 @ $49.10 · Sale (S): 1,900 @ $87.06 · Sale (S): 600 @ $88.10 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2026-01-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 3,000 @ $31.20 · Option exercise (M): 2,500 @ $49.10 · Sale (S): 400 @ $66.68 · Sale (S): 4,900 @ $67.99 · Sale (S): 200 @ $68.52 · Option exercise (M): 3,000 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-17 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 12,563 @ $49.10 · Option exercise (M): 12,000 @ $27.67 · Option exercise (M): 3,000 @ $31.20 · Sale (S): 14,505 @ $81.56 · Sale (S): 7,959 @ $82.34 · Sale (S): 4,099 @ $83.45 · +4 more | EDGAR |
| 2025-06-26 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
| 2025-06-03 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 5,000 @ $29.55 · Sale (S): 5,000 @ $49.04 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-12-02 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 2,500 @ $29.55 · Sale (S): 2,500 @ $49 · Option exercise (M): 2,500 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | Kymera Therapeutics, Inc. (KYMR) | Option exercise (M): 8,500 @ $29.55 · Option exercise (M): 5,000 @ $14.18 · Sale (S): 6,350 @ $47.75 · Sale (S): 7,150 @ $48.75 · Option exercise (M): 8,500 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2024-06-20 | 4 | Kymera Therapeutics, Inc. (KYMR) | Grant/award (A): 16,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1744425 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →